ASPEN PHARMACARE HOLDINGS LIMITED - Aspens Results for the twelve months ended 30 June 2020 and Results Presentation

Aspen’s Results for the twelve months ended 30 June 2020 and Results Presentation

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen” or “the Company”)


ASPEN’S RESULTS FOR THE TWELVE MONTHS ENDED 30 JUNE 2020 AND RESULTS PRESENTATION


Shareholders are advised that Aspen intends releasing its results for the twelve months ended 30 June 2020
on SENS after the market closes on Wednesday, 9 September 2020 with a presentation to members of the
investment community taking place via webcast on 10 September 2020 at 08:30.

All interested stakeholders are invited to watch the live webcast which can be accessed using the following
link: https://www.corpcam.com/Aspen10092020.

The slides accompanying the presentation will be available on Aspen’s website (www.aspenpharma.com)
home page shortly before the commencement of the presentation on 10 September 2020.

A playback of the webcast will be made available on our website approximately 2 hours after the
presentation.


Durban
8 September 2020

Sponsor:
Investec Bank Limited

Date: 08-09-2020 12:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.